imipramine has been researched along with Acute Promyelocytic Leukemia in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xia, Z | 1 |
| Bergstrand, A | 1 |
| DePierre, JW | 1 |
| Nässberger, L | 1 |
1 other study available for imipramine and Acute Promyelocytic Leukemia
| Article | Year |
|---|---|
The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation.
Topics: Antidepressive Agents; Apoptosis; Caspase 3; Caspases; Citalopram; Clomipramine; DNA Fragmentation; | 1999 |